Stockscreener 앱 받기
16.27
4.69%
-0.80
전일 마감가:
$17.07
열려 있는:
$16.97
하루 거래량:
325.50K
Relative Volume:
0.85
시가총액:
$749.21M
수익:
$526.52M
순이익/손실:
$32.53M
주가수익비율:
24.09
EPS:
0.6755
순현금흐름:
$26.48M
1주 성능:
-5.74%
1개월 성능:
+3.17%
6개월 성능:
+42.34%
1년 성능:
+33.91%
1일 변동 폭
$16.25
$17.06
1주일 범위
$16.25
$17.20
52주 변동 폭
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Compare CLB vs SLB, BKR, HAL, TS, FTI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
16.27 | 760.26M | 526.52M | 32.53M | 26.48M | 0.6755 |
SLB
Slb Ltd
|
51.49 | 77.94B | 35.69B | 3.45B | 4.54B | 2.3617 |
BKR
Baker Hughes Company
|
61.49 | 62.31B | 27.73B | 2.62B | 2.54B | 2.605 |
HAL
Halliburton Co
|
37.51 | 31.39B | 22.18B | 1.29B | 1.67B | 1.5088 |
TS
Tenaris S A Adr
|
58.92 | 30.23B | 12.00B | 1.98B | 2.02B | 3.6742 |
FTI
Technipfmc Plc
|
72.00 | 29.51B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-06-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2023-04-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-10-07 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-09-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-07-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-11-11 | 재확인 | Cowen | Market Perform |
| 2020-10-13 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-09-29 | 업그레이드 | ABN Amro | Sell → Hold |
| 2020-07-16 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-01-31 | 재확인 | Cowen | Market Perform |
| 2020-01-30 | 재개 | Johnson Rice | Buy |
| 2020-01-14 | 개시 | Bernstein | Mkt Perform |
| 2020-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-12-31 | 재확인 | Cowen | Market Perform |
| 2019-07-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | 업그레이드 | Tudor Pickering | Hold → Buy |
| 2018-12-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2018-11-01 | 업그레이드 | ABN Amro | Sell → Buy |
| 2018-10-29 | 재확인 | Cowen | Market Perform |
모두보기
Core Laboratories Inc 주식(CLB)의 최신 뉴스
Retail Surge: Is Core Laboratories Inc part of any major index2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn
Update Recap: Will Core Laboratories Inc announce a stock splitQuarterly Risk Review & High Conviction Buy Zone Alerts - baoquankhu1.vn
Insider Sell: Can Core Laboratories Inc be the next market leaderTrade Exit Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories (CLB) director gains restricted stock and 8,069 shares vest - Stock Titan
Press Releases about Core Laboratories Inc. Common Stock (NYSE:CLB) - FinancialContent
Director at Core Laboratories (NYSE: CLB) gains new share awards - Stock Titan
Core Laboratories (NYSE: CLB) director gets 7,895-share stock grant - Stock Titan
Core Laboratories (NYSE: CLB) director gets 7,895 restricted shares - Stock Titan
Core Laboratories (NYSE: CLB) director receives 7,895 RSUs, 8,069 shares vest - Stock Titan
Core Laboratories (CLB) director receives 7,895 restricted shares and holds 54,397 - Stock Titan
Oilfield Services Stocks Q4 Teardown: Core Laboratories (NYSE:CLB) Vs The Rest - Yahoo Finance
CLB PE Ratio & Valuation, Is CLB Overvalued - Intellectia AI
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
CLB SEC FilingsCore Laboratories Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Core Laboratories Inc. (CLB) Stock Forecasts - Yahoo! Finance Canada
Core Laboratories : 2025 Annual Report - marketscreener.com
Core Laboratories Inc. (CLB) Stock forecasts - Yahoo Finance UK
Death Cross: Is Core Laboratories Inc likely to announce a buyback2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Core Laboratories (NYSE: CLB) details 2026 director elections, pay plan and KPMG ratification - Stock Titan
Can Core Laboratories Inc be the next market leaderPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Core Laboratories Hits Day High with Strong 7.25% Intraday Surge - Markets Mojo
Precision Trading with Core Laboratories Inc. (CLB) Risk Zones - Stock Traders Daily
Middle East conflict weighs on Core Laboratories' Q1 outlook - MSN
Zacks Research Brokers Boost Earnings Estimates for CLB - Defense World
Core Laboratories (NYSE:CLB) Trading Up 5.5%Here's Why - MarketBeat
Core Laboratories and Gevo Stocks Trade Up, What You Need To Know - TradingView
Aug Setups: Is Core Laboratories Inc likely to announce a buyback2026 Trading Volume Trends & Technical Entry and Exit Tips - baoquankhu1.vn
Vanguard (NYSE: CLB) amendment shows 0 beneficial shares after realignment - Stock Titan
Core Laboratories: Profit Margins Are Too Small To Get Excited About (NYSE:CLB) - Seeking Alpha
Middle East Tensions Impact Core Laboratories' First Quarter Forecast - Bitget
Core Laboratories Inc stock faces pressure amid oilfield services slowdown and Q4 earnings anticipat - AD HOC NEWS
Middle East Conflict Weighs On Core Laboratories' Q1 Outlook - Yahoo Finance
History Review: Is Core Laboratories Inc backed by strong institutional buying2026 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Gap DownHere's Why - MarketBeat
Here’s Why Maintaining a Hold Position Is Suitable for Core Laboratories Shares at This Time - Bitget
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - Yahoo Finance
Core Laboratories Cuts Q1 2026 Guidance Amid Mideast Turmoil - TipRanks
Core Laboratories cuts Q1 2026 guidance on Middle East conflict By Investing.com - Investing.com Australia
Core Lab (CLB) Revises Q1 Revenue Forecast Amid Regional Challen - GuruFocus
Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict - Moomoo
Stocks to Watch: Core Laboratories, Bark - Moomoo
Core Laboratories (CLB) Shares Drop 4.7% After Lower Q1 Guidance - GuruFocus
Core Labs cuts Q1 guidance, citing impact of Middle East war (CLB:NYSE) - Seeking Alpha
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - Bitget
Core Laboratories cuts Q1 2026 guidance on Middle East conflict - Investing.com
Core Laboratories (CLB) Shares Fall 5% Following Preliminary Q1 Results - GuruFocus
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07... - Benzinga
Core Laboratories Expects Q1 2026 Revenue An... - Benzinga
Core revises Q1 2026 guidance, now sees revenue $119M-$123M and EPS $0.05-$0.07 - tradingview.com
Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil - stocktitan.net
Core Laboratories Inc (CLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
자본화:
|
볼륨(24시간):